Floatz logo

Omacetaxine

Induction Chemotherapy

The First Affiliated Hospital of Soochow UniversityPhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Induction Chemotherapy cohort.

Asset / SponsorPhaseRating
Cytosin-Arabinosid
The First Affiliated Hospital of Soochow University
Phase 3B
Idarubicine
The First Affiliated Hospital of Soochow University
Phase 3B
FILGRASTIM
The First Affiliated Hospital of Soochow University
Phase 3B
Aclarubicin
The First Affiliated Hospital of Soochow University
Phase 3B
Decitabine
The First Affiliated Hospital of Soochow University
Phase 3B

Same molecule, other indications

Omacetaxine is also rated in:

Acute Myeloid Leukaemia; Myelodysplastic Syndromes;Chronic Myelomonocytic LeukemiaDormant
BB
Indicative ·
65 / 100
View asset →
Elderly Patients (60-75 Years)Dormant
B
Indicative ·
60 / 100
View asset →
acute myeloid leukemiaDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →